The Interplay between Alpha-Synuclein Clearance and Spreading
about
Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's DiseaseBifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ.α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease.Fasudil attenuates aggregation of α-synuclein in models of Parkinson's diseaseBlood Plasma of Patients with Parkinson's Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity.Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type mice.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Treatments and compositions targeting α-synuclein: a patent review (2010-2016).The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.From the Cover: Alterations in Optineurin Expression and Localization in Pre-clinical Parkinson's Disease ModelsUpregulation of autophagy-related gene 5 protects dopaminergic neurons in a zebrafish model of Parkinson's disease.A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues.Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cellsThe Molecular Physiopathogenesis of Islet Amyloidosis.Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson's disease.Parkinson's Disease Is Not Simply a Prion Disorder.Alpha-synuclein, proteotoxicity and Parkinson's disease: Search for neuroprotective therapy.Effect of the cross-talk between autophagy and endoplasmic reticulum stress on Mn-induced alpha-synuclein oligomerization.Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.Association of exercise-induced autophagy upregulation and apoptosis suppression with neuroprotection against pharmacologically induced Parkinson's disease.Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy.
P2860
Q28079379-F8FF84F0-28F0-4EAC-8572-EED8DB1512D0Q36185625-C9D3C154-8C39-4452-86D6-7254221E9666Q36608855-1FF8FC69-8472-4ABF-BB74-80B01663BF43Q36825541-FDA2E4C3-0FAF-4ADA-A1AC-5ECA8F2E96E7Q37443736-83934E7A-7AE1-4F59-9A20-2778C93FFC13Q37555992-E1C9B96C-2CDE-4DC0-B2E3-E0AB89AA0126Q38669105-49BF6C2F-A5D5-430A-B491-C12E45C82228Q39007523-CC55850E-F124-48FC-B0DA-A1202CD793C0Q39148146-F3E58107-C4AE-4A42-9C89-F61B85513867Q41658088-90DC9B9B-E20E-4979-ADBB-60A3E974EFABQ41996328-075F6F27-49DA-436E-9538-D59951B16322Q42285864-55960245-36AD-4F6D-8FF3-10A0D4F576B9Q42317471-D0ACFD9A-A730-461A-9B73-CCD6FF17903AQ46282033-BDE5FC28-8CE7-4517-9F50-1FA914AD5393Q47123483-C3516866-CFA1-415E-89FF-4BBF29B1B7B3Q47314960-A90B4B01-0E7A-407D-893E-9D81A5B56916Q47348189-54A2BBE4-4D3F-4A46-A326-C3052610E397Q47386127-F4F4E77A-734E-4C9C-A2D5-9DDD7761B5C8Q52373049-278DB398-2D27-49CB-AF2F-418131791A64Q55107196-8EBDDB32-7D71-4BBB-9164-987A5DB9CC8AQ55691017-A076768B-24DF-4241-80B1-FC26B3105228
P2860
The Interplay between Alpha-Synuclein Clearance and Spreading
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Interplay between Alpha-Synuclein Clearance and Spreading
@ast
The Interplay between Alpha-Synuclein Clearance and Spreading
@en
type
label
The Interplay between Alpha-Synuclein Clearance and Spreading
@ast
The Interplay between Alpha-Synuclein Clearance and Spreading
@en
prefLabel
The Interplay between Alpha-Synuclein Clearance and Spreading
@ast
The Interplay between Alpha-Synuclein Clearance and Spreading
@en
P2093
P2860
P921
P356
P1433
P1476
The Interplay between Alpha-Synuclein Clearance and Spreading
@en
P2093
Anna Villar-Piqué
Tiago Fleming Outeiro
Tomás Lopes da Fonseca
P2860
P304
P356
10.3390/BIOM5020435
P5008
P577
2015-04-14T00:00:00Z